Diagnostic criteria of the myeloproliferative disorders (MPD): Essential thrombocythaemia, polycythaemia vera and chronic megakaryocytic granulocytic metaplasia

Netherlands Journal of Medicine

Volumn 51, Issue 2, 1997, Pages 57-64

  Michiels, J J ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Goodheart Institute   (Netherlands)

Author keywords

Chronic megakaryocytie granulocytic metaplasia; Essential thromhocythaemia; Myeloproliferative disorders; Polycythaemia vera

Indexed keywords

ACUTE MEGAKARYOCYTIC LEUKEMIA; CHROMOSOME ANALYSIS; HISTOPATHOLOGY; HUMAN; METAPLASIA; MYELOPROLIFERATIVE DISORDER; OSTEOSCLEROSIS; PHILADELPHIA 1 CHROMOSOME; POLYCYTHEMIA VERA; REVIEW; SCLEROSIS; THROMBOCYTHEMIA;

BONE MARROW; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDERS; POLYCYTHEMIA VERA; PRACTICE GUIDELINES; THROMBOCYTHEMIA, HEMORRHAGIC;

EID: 0030858716     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2977(97)00018-1     Document Type: Review

References (45)

1. Gilbert HS. The spectrum of myeloproliferative disorders. Med Clin North Am 1973;57:355-393.
2. Ward HP, Black MH. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine 1975;50:357-419.
3. Laszlo J. Myeloproliferative disorders (MPD): myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia. Semin Hematol 1975;12:409-432.
4. Michiels JJ. The myeloproliferative disorders. An historical appraisal and personal experiences. Leuk Lymphoma 1996;22(suppl 1):1-14.
5. Michiels JJ, Prins ME, Hagemeijer A, et al. Philadelphia chromosome-positive essential thrombocythemia and megakaryoblast leukemia. Am J Clin Pathol 1987;88:645-652.
6. Murphy S, Iland H, Rosenthal D, Laszlo J. Essential thrombocythemia: An interim report from the Polycythemia Vera Study Group. Semin Hematol 1986;23:177-182.
7. Kutti J, Wadenvik H. Diagnostic and differential criteria of essential thrombocythemia and reactive thrombocytosis. Leuk Lymphoma 1996;22(suppl 1):41-45.
8. Dudley JM, Messinaezy M, Eridani S, et al. Primary thrombocythaemia: diagnostic criteria and a simple scoring system for positive diagnosis, Br J Haematol 1992;39:131-136.
9. Berlin MI. Diagnosis and classification of the polycythemias. Semin Hematol 1975;12:339-351.
10. Polycythemia vera and the myeloproliferative disdorders. Berlin: Wasserman, Berk; Philadelphia: W.B. Saunders Company, 1995.
11. Pearson TC, Wetherley-Mein G. The course and complications of idiopathic erythrocytosis. Clin Lab Haematol 1979; 1:189-196.
12. Najean Y, Triebel F, Dresch C. Pure erythrocytosis: Reappraisal of a study of 51 cases. Am J Hematol 1981;10:129-136.
13. Ellis JT, Silver RT, Coleman M, Geller SA. The bone marrow in polycythemia vera. Semin Hematol 1975;12:433-444.
14. Lundin PM, Ridell B, Weinfeld A. The significance of bone marrow morphology for the diagnosis of polycythemia vera. Scand J Haematol 1972;9:271-282.
15. Weinreb MJ, Chi-Fang SHIH. Spurious polycythemia. Semin Hematol 1975;12:397-407.
16. Burkhardt R, Bartl R, Jäger K, et al. Chronic myeloproliferative disorders (CMPD). Pathol Res Pract 1984;179:131-186.
17. Georgii A, Vykoupil KF, Thiele J. Chronic megakaryocytic granulocytic myelosis - CMGM. Virchows Arch A Path Anat Histol 1980;389:253-268.
18. Georgii A, Vykoupil K-F, Buhr Th, et al. Chronic myeloproliferative disorders in bone marrow biopsies. Path Res Pract 1990;186:3-27.
19. Georgii A, Buhr T, Buesche G, Kreft A, Choritz H. Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies. Leuk Lymphoma 1996;22(suppl 1):15-29.
20. 32. Acta Med Scand 1953;145:311-314.
21. Franzen S, Strenger G, Zajicek J. Microplanimetric studies on megakaryocytes in chronic granulocytic leukaemia and polycythaemia vera. Acta Haematol 1961;26:182-193.
22. Michiels JJ, Ten Kate FWJ. Erythromelalgia in thrombocythemia of various myeloproliferative disorders. Am J Hematol 1992;39:131-136.
23. Thiele J, Zankovich R, Schneider G, Kremer B, Fischer R, Diehl V. Primary (essential) thrombocythemia versus polycythemia vera rubra. A histomorphometric analysis of bone marrow features in trephine biopsies. Anal Quant Cytol Histol 1988;10:375-382.
24. Thiele J, Wagner S, Degel C, et al. Megakaryocyte precursors (pro-and megakaryoblasts) in bone marrow tissue from patients with reactive thrombocytosis, polycythemia vera and primary (essential) thrombocythemia. Virchows Arch B Cell Pathol 1990;58:295-302.
25. Kaloutsi V, Fritsch RS, Buhr T, Restrepo-Specht I, Widjaja W, Georgii A. Megakaryocytes in chronic myeloproliferative disorders: numerical density correlated between different entities. Virchows Arch A Pathol Anat 1991;418:493-497.
26. Buhr T, Georgii A, Schuppan O, Amor A, Kaloutsi V. Histologic findings in bone marrow biopsies of patients with thrombocythemic cell counts. Ann Hematol 1992;64:286-291.
27. Dickstein J, Vardiman JW. Hematopathologic findings in the myeloproliferative disorders. Semin Hematol 1995;22:355-373.
28. Hand HJ, Laszlo J, Peterson P, et al. Essential thrombocythemia: clinical and laboratory characteristics at presentation. Trans Assoc Am Phys 1983;XCVI:165-174.
29. Michiels JJ, Abels J, Steketee J, Van Vliet HHDM, Vuzevski VD. Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia. Ann Intern Med 1985;102:466-471.
30. Michiels JJ, Koudstaal PJ, Mulder AH, van Vliet HHDM. Transient neurologic and ocular manifestations in primary thrombocythemia. Neurology 1993;43:1107-1110.
31. Van Genderen PJJ, Michiels JJ. Primary thrombocythemia: diagnosis, clinical manifestations and management Ann Hematol 1993;67:57-62.
32. Westwood N, Dudley JM, Sawyer B, Messinezy M, Pearson TC. Primary polycythaemia: diagnosis by non-conventional positive criteria. Eur J Haematol 1993;51:228-232.
33. Messinezy M, Sawyer B, Westwood NB, Pearson TC. Idiopathic erythrocytosis: additional new study techniques suggest a heterogenous group. Eur J Haematol 1994;53:163-167.
34. Westwood N, Pearson TC. Studies of haematopoietic progenitor cells using clonogenic culture techniques in chronic myeloproliferative disorders. Leuk Lymphoma 1996;22(suppl 1):95-103.
35. Chelloul N, Briere J, Laval-Jeantet M, Najean Y, Vorhauer W, Jacquilat C. Prognostic of myeloid metaplasia with myelofibrosis. Biomedicine 1976;24:272-280.
36. Thiele J, Zankovich R, Steinberg Th, Fischer R, Diehl V. Agnogenic myeloid metaplasia (AMM) - correlation of bone marrow lesions with laboratory data: a longitudinal clinicopathological study on 114 patients. Hematol Oncol 1989;7:327-343.
37. Smith RE, Chelmowski MK, Szabo E. Myelofibrosis: a concise review of clinical and pathologic features and treatment. Am J Hematol 1988;29:174-180.
38. Bartl R, Frisch B, Wilmans W. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD). Eur J Haematol 1993;50:41-52.
39. Reilly JT. Pathogenesis of idiopathic myelofibrosis: present status and future directions (Annotation). Br J Haematol 1994;88:1-8.
40. Tefferi A, Silverstein MN, Noël P. Agnogenic myeloid metaplasia. Semin Hematol 1995;22:327-333.
41. Dupriez B, Morel P, Demory JL, et al.. Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood 1996;88:1013-1018.
42. Georgii A, Vikoupil KF. Pathologische Anatomie der megakaryocytäre Myelose. In: Gross R, van de Loo J, eds. Leukämie. Berlin-Heidelberg-New York: Springer, 1972:25-28.
43. Georgii A, Vikoupil KF. Histologisch-bioptische Klassifizierung myeloproliferatieve Erkrankungen. In: Stacher A, Höcker O, eds. Erkrankungen der Myelopoiese, Leukämie, myeloproliferatives Syndrom, Polyzythämie. Vienna: Urban and Schwarzenberg 1976:47-58.
44. Thiele J, Ballard Ch, Georgii A, Vykoupil KF. Chronic megakaryocytic granulocytic myelosis - an electron microscopic study. Virchows Arch A Pathol Anat Histol 1977; 373:191-211.
45. Thiele J, Kvasnicka H-M, Werden C, Zankovich R, Diehl V, Fischer R. Idiopathic primary osteo-myelosclerosis: a clinicopathological study on 208 patients with special emphasis on evolution of disease feature, differentiation from essential thrombocythemia and variables of prognostic impact. Leuk Lymphoma 1996;22:303-317.